DEN170073 is an FDA 510(k) submission (not cleared) for the ContaCT. Classified as Radiological Computer-assisted Triage And Notification Software (product code QAS), Class II - Special Controls.
Submitted by Viz.Al, Inc. (San Francisco, US). The FDA issued a Not Cleared (DENG) decision on February 13, 2018 after a review of 137 days.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2080 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway requires demonstration of substantial equivalence to a legally marketed predicate device - a standard the FDA determined was not met in this submission.
Device pattern: Incremental AI imaging tool. Elevated predicate reliance profile. This submission did not achieve clearance, indicating the FDA determined the device lacked sufficient predicate equivalence under the Radiology review framework.
View all Viz.Al, Inc. devices